Dovitinib, a potential new treatment for osteosarcoma, receives Orphan Drug Designation from the U.S. FDA
BOSTON, MA, USA, October 13, 2023 /EINPresswire.com/ -- Oncoheroes Biosciences, a biotech focused on advancing new therapies for childhood cancer, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation (ODD) to …